TCS transforms QIAGEN's GeneGlobe to improve customer experience

25 Feb 2020 Evaluate

Tata Consultancy Services (TCS) has transformed QIAGEN's GeneGlobe, a genomics-based research platform for biology and biomedical researchers, to improve customer experience.

TCS adopted a cloud-based microservices architecture and revamped the GeneGlobe platform by leveraging industry-best DevOps practices and design thinking approaches. The new platform, GeneGlobe - Design & Analysis Hub, offers an intuitive interface, helping researchers to find the right product in just three steps.

Powerful algorithms link products to biological targets, so researchers can explore and expedite decisions on products within the relevant context. Personalized dashboards and product builders are now easier to use and enable the creation of virtually any custom product for a specific research question. This transformation has helped QIAGEN to boost overall digital revenue.

Tata Consultancy Services is an IT services, consulting and business solutions provider that has been partnering with the world’s largest businesses in their transformation journeys for the last fifty years.

TCS Share Price

3108.05 -54.95 (-1.74%)
20-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3108.05
Infosys 1657.70
HCL Tech. 1690.75
Wipro 239.95
Tech Mahindra 1678.30
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×